Correlation Between Aclaris Therapeutics and Qiagen NV
Can any of the company-specific risk be diversified away by investing in both Aclaris Therapeutics and Qiagen NV at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aclaris Therapeutics and Qiagen NV into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Aclaris Therapeutics and Qiagen NV, you can compare the effects of market volatilities on Aclaris Therapeutics and Qiagen NV and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aclaris Therapeutics with a short position of Qiagen NV. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aclaris Therapeutics and Qiagen NV.
Diversification Opportunities for Aclaris Therapeutics and Qiagen NV
-0.35 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Aclaris and Qiagen is -0.35. Overlapping area represents the amount of risk that can be diversified away by holding Aclaris Therapeutics and Qiagen NV in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Qiagen NV and Aclaris Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aclaris Therapeutics are associated (or correlated) with Qiagen NV. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Qiagen NV has no effect on the direction of Aclaris Therapeutics i.e., Aclaris Therapeutics and Qiagen NV go up and down completely randomly.
Pair Corralation between Aclaris Therapeutics and Qiagen NV
Given the investment horizon of 90 days Aclaris Therapeutics is expected to generate 7.63 times more return on investment than Qiagen NV. However, Aclaris Therapeutics is 7.63 times more volatile than Qiagen NV. It trades about 0.06 of its potential returns per unit of risk. Qiagen NV is currently generating about 0.03 per unit of risk. If you would invest 217.00 in Aclaris Therapeutics on November 2, 2024 and sell it today you would earn a total of 22.00 from holding Aclaris Therapeutics or generate 10.14% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Aclaris Therapeutics vs. Qiagen NV
Performance |
| Timeline |
| Aclaris Therapeutics |
| Qiagen NV |
Aclaris Therapeutics and Qiagen NV Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Aclaris Therapeutics and Qiagen NV
The main advantage of trading using opposite Aclaris Therapeutics and Qiagen NV positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aclaris Therapeutics position performs unexpectedly, Qiagen NV can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Qiagen NV will offset losses from the drop in Qiagen NV's long position.| Aclaris Therapeutics vs. Neogen | Aclaris Therapeutics vs. Qiagen NV | Aclaris Therapeutics vs. Sotera Health Co | Aclaris Therapeutics vs. RadNet Inc |
| Qiagen NV vs. Neogen | Qiagen NV vs. Aclaris Therapeutics | Qiagen NV vs. IQVIA Holdings | Qiagen NV vs. Medpace Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Other Complementary Tools
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |